| 加拿大药品特别准入计划对我国同情用药制度的启示 |
| |
| 引用本文： | 任磊,葛其南,舒丽芯.加拿大药品特别准入计划对我国同情用药制度的启示[J].中国现代应用药学,2020,37(6):659-663. |
| |
| 作者姓名： | 任磊 葛其南 舒丽芯 |
| |
| 作者单位： | 海军军医大学药学院军队药材保障论证中心,上海市药学会,海军军医大学药学院军队药材供应管理教研室 |
| |
| 基金项目： | 后勤科研课题（BWS13B099）；后勤科研重点课题（BWS17J020） |
| |
| 摘 要： | 目的在新型冠状病毒肺炎患者没有特效药可治的背景下，为完善我国同情用药制度提供国外经验借鉴。方法通过文献研究等方法对加拿大的特别准入计划的具体内容进行研究。结果 加拿大具有相对完善的制度体系，值得我国借鉴。结论 结合我国具体国情，从医生、政府、企业三个维度进行同情用药制度的完善。
|
| 关 键 词： | 加拿大 特别准入计划 同情用药制度 新型冠状病毒肺炎 拓展性用药 |
| 收稿时间： | 2020/2/29 0:00:00 |
| 修稿时间： | 2020/3/20 0:00:00 |
Enlightenment of Canada's Drug Special Access Program on China's Compassionate Use System |
| |
| REN Lei,GE Qinan,SHU Lixin.Enlightenment of Canada''s Drug Special Access Program on China''s Compassionate Use System[J].The Chinese Journal of Modern Applied Pharmacy,2020,37(6):659-663. |
| |
| Authors: | REN Lei GE Qinan SHU Lixin |
| |
| Institution: | Demonstration Center of Military Medical Supply, School of Pharmacy, Naval Medical University,Shanghai Pharmaceutical Association,Department of Military Medical Supply Administration, School of Pharmacy, Naval Medical University |
| |
| Abstract: | OBJECTIVE To provide foreign experience for the improvement of China''s compassionate use system under the background that there is no specific medicine for patients with COVID-19. METHODS Studied the specific content of Canada''s special access program through literature research methods and so on. RESULTS Canada has a relatively perfect system, which was worthy of our country''s reference. CONCLUSION According to the specific national conditions of our country, compassionate use system should be improved from three dimensions:doctor, government and drug manufacturer. |
| |
| Keywords: | Canada Special Access Program compassionate use system COVID-19 expanded access to investigational drug |
|
| 点击此处可从《中国现代应用药学》浏览原始摘要信息 |
| 点击此处可从《中国现代应用药学》下载免费的PDF全文 |
